These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36633470)

  • 41. Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.
    Allegretti AS; Israelsen M; Krag A; Jovani M; Goldin AH; Schulman AR; Winter RW; Gluud LL
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD005162. PubMed ID: 29943803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vasoconstrictor Therapy for Acute Kidney Injury Hepatorenal Syndrome: A Meta-Analysis of Randomized Studies.
    Singal AK; Palmer G; Melick L; Abdallah M; Kwo P
    Gastro Hep Adv; 2023; 2(4):455-464. PubMed ID: 39132033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis.
    Olson JC; Subramanian RM
    PLoS One; 2024; 19(1):e0296690. PubMed ID: 38285703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Terlipressin and albumin combination treatment in hepatorenal syndrome.
    Danalioglu A; Cakaloglu Y; Karaca C; Aksoy N; Akyuz F; Ozdil S; Demir K; Besisik F; Boztas G; Mungan Z; Kaymakoglu S; Okten A
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccciii-cccv. PubMed ID: 15244209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Terlipressin vs Midodrine Plus Octreotide for Hepatorenal Syndrome-Acute Kidney Injury: A Propensity Score-Matched Comparison.
    Gonzalez SA; Chirikov VV; Wang WJ; Huang X; Jamil K; Simonetto DA
    Clin Transl Gastroenterol; 2023 Dec; 14(12):e00627. PubMed ID: 37622521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P;
    Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis.
    Rodríguez E; Elia C; Solà E; Barreto R; Graupera I; Andrealli A; Pereira G; Poca M; Sánchez J; Guevara M; Soriano G; Alessandria C; Fernández J; Arroyo V; Ginès P
    J Hepatol; 2014 May; 60(5):955-61. PubMed ID: 24447876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatorenal syndrome in patients with cirrhosis.
    Moreau R
    J Gastroenterol Hepatol; 2002 Jul; 17(7):739-47. PubMed ID: 12121502
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1.
    Boyer TD; Sanyal AJ; Garcia-Tsao G; Regenstein F; Rossaro L; Appenrodt B; Gülberg V; Sigal S; Bexon AS; Teuber P;
    Liver Transpl; 2011 Nov; 17(11):1328-32. PubMed ID: 21837734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Response to Terlipressin and albumin is associated with improved outcome in patients with cirrhosis and hepatorenal syndrome].
    Nguyen-Tat M; Götz E; Scholz-Kreisel P; Ahrens J; Sivanathan V; Schattenberg J; Rey JW; Wörns MA; Galle PR; Marquardt JU
    Dtsch Med Wochenschr; 2015 Jan; 140(2):e21-6. PubMed ID: 25612289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.
    Moreau R; Durand F; Poynard T; Duhamel C; Cervoni JP; Ichaï P; Abergel A; Halimi C; Pauwels M; Bronowicki JP; Giostra E; Fleurot C; Gurnot D; Nouel O; Renard P; Rivoal M; Blanc P; Coumaros D; Ducloux S; Levy S; Pariente A; Perarnau JM; Roche J; Scribe-Outtas M; Valla D; Bernard B; Samuel D; Butel J; Hadengue A; Platek A; Lebrec D; Cadranel JF
    Gastroenterology; 2002 Apr; 122(4):923-30. PubMed ID: 11910344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Respiratory events with terlipressin and albumin in hepatorenal syndrome: A review and clinical guidance.
    Allegretti AS; Subramanian RM; Francoz C; Olson JC; Cárdenas A
    Liver Int; 2022 Oct; 42(10):2124-2130. PubMed ID: 35838488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Poor outcomes with treatment of hepatorenal syndrome type 1 with splanchnic vasoconstrictors and albumin: report of seven cases and review of the literature.
    Kalil JR; Cerqueira LA; Barbosa DS; Motta MP; Nery Mda S; Bittencourt PL
    Arq Gastroenterol; 2009; 46(3):214-8. PubMed ID: 19918689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.
    Uriz J; Ginès P; Cárdenas A; Sort P; Jiménez W; Salmerón JM; Bataller R; Mas A; Navasa M; Arroyo V; Rodés J
    J Hepatol; 2000 Jul; 33(1):43-8. PubMed ID: 10905585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1.
    Gifford FJ; Morling JR; Fallowfield JA
    Aliment Pharmacol Ther; 2017 Mar; 45(5):593-603. PubMed ID: 28052382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population.
    Reddy KR; Weinberg EM; Gonzalez SA; Izzy MJ; Simonetto DA; Frederick RT; Rubin RA; Fricker Z; Ikahihifo-Bender J; Harte M; Garcia S; Campbell K; Olofson A; Razavi RF; James JM; Patel H; Kim-Lee G; Witkiewicz S; Tobin W; Jamil K
    Liver Transpl; 2024 Oct; 30(10):1026-1038. PubMed ID: 38771635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High age and low sodium urine concentration are associated with poor survival in patients with hepatorenal syndrome.
    Hinz M; Wree A; Jochum C; Bechmann LP; Saner F; Gerbes AL; Gerken G; Canbay A
    Ann Hepatol; 2013; 12(1):92-9. PubMed ID: 23293199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Limited Progress in Hepatorenal Syndrome (HRS) Reversal and Survival 2002-2018: A Systematic Review and Meta-Analysis.
    Thomson MJ; Taylor A; Sharma P; Lok AS; Tapper EB
    Dig Dis Sci; 2020 May; 65(5):1539-1548. PubMed ID: 31571102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatorenal syndrome. Long-term treatment with terlipressin as a bridge to liver transplantation.
    Ganne-Carrié N; Hadengue A; Mathurin P; Durand F; Erlinger S; Benhamou JP
    Dig Dis Sci; 1996 Jun; 41(6):1054-6. PubMed ID: 8654133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography.
    Premkumar M; Kajal K; Reddy KR; Izzy M; Kulkarni AV; Duseja AK; Sihag KB; Divyaveer S; Gupta A; Taneja S; De A; Verma N; Rathi S; Bhujade H; Chaluvashetty SB; Roy A; Kumar V; Siddhartha V; Singh V; Bahl A
    Hepatology; 2024 May; 79(5):1048-1064. PubMed ID: 37976391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.